SNT Biotech founder and CEO Shital Daftari was featured on NBC 5 Chicago's "Tech Trends" segment with reporter Charlie Wojciechowski, discussing how SNT Biotech is helping more women complete cervical cancer screening from home.
Nearly 25 million U.S. women are behind on, or have never had, cervical cancer screening, a cancer that is almost always preventable when caught early. SNT Biotech partners with health plans to deliver an end-to-end at-home screening solution: kitting, multilingual member outreach, laboratory testing in its own CLIA-accredited lab, and results returned to patients and their providers.
Watch the full segment on NBC 5 Chicago.